| Title : Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study - Pape_2020_Cancers.(Basel)_12_ |
| Author(s) : Pape UF , Kasper S , Meiler J , Sinn M , Vogel A , Muller L , Burkhard O , Caca K , Heeg S , Buchner-Steudel P , Rodriguez-Laval V , Kuhl AA , Arsenic R , Jansen H , Treasure P , Utku N |
| Ref : Cancers (Basel) , 12 : , 2020 |
| Abstract : Pape_2020_Cancers.(Basel)_12_ |
| ESTHER : Pape_2020_Cancers.(Basel)_12_ |
| PubMedSearch : Pape_2020_Cancers.(Basel)_12_ |
| PubMedID: 33121007 |
Pape UF, Kasper S, Meiler J, Sinn M, Vogel A, Muller L, Burkhard O, Caca K, Heeg S, Buchner-Steudel P, Rodriguez-Laval V, Kuhl AA, Arsenic R, Jansen H, Treasure P, Utku N (2020)
Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study
Cancers (Basel)
12 :
Pape UF, Kasper S, Meiler J, Sinn M, Vogel A, Muller L, Burkhard O, Caca K, Heeg S, Buchner-Steudel P, Rodriguez-Laval V, Kuhl AA, Arsenic R, Jansen H, Treasure P, Utku N (2020)
Cancers (Basel)
12 :